Anti-Aging Treatments at Forefront of Astellas’ €80M UK Acquisition
Japanese pharma giant Astellas has acquired the UK biotech Nanna Therapeutics for up to €80M…
28/04/2020 - 3 minutes
News and Trends
Series A Round Boosts Swedish Synthetic Biology Player by €6.4M
The Swedish synthetic biology company EnginZyme has raised a Series A funding round to the…
27/04/2020 - 4 minutes
Big €10M Seed Round Funds New Class of Cancer Drugs in Switzerland
The Swiss biotech FoRx Therapeutics has raised an impressive €10M in seed funding to develop…
24/04/2020 - 3 minutes
First Volunteers Dosed with European Coronavirus Vaccine
The first European vaccine for coronavirus disease to enter clinical trials has been administered to…
24/04/2020 - 3 minutes
UK Startup to Manufacture Cell and Gene Therapies with Microfluidics
The UK company MicrofluidX has closed a €1.6M (£1.4 M) seed funding round to develop…
24/04/2020 - 3 minutes
Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies
The UK cell conversion startup Mogrify and the US genomic medicine company Sangamo have reached…
23/04/2020 - 3 minutes
Sofinnova Invests €20M in Three Italian Rare Disease Biotechs
The French VC firm Sofinnova Partners has invested €20M in three Italian biotech companies via…
23/04/2020 - 3 minutes
€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating
The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against…
22/04/2020 - 3 minutes
Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia
The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…
21/04/2020 - 3 minutes
French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders
The microbiome company LNC Therapeutics has entered into a licensing agreement to use a specific…
17/04/2020 - 3 minutes
Is New Enzyme Technology Key to Solving Society’s Plastic Problem?
A new type of enzyme developed by the French company Carbios can break down more…
17/04/2020 - 4 minutes
Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology
The Irish company Avectas has closed a Series C round to develop cell therapies that…
16/04/2020 - 2 minutes
